Inogen (INGN) announced the following leadership appointments designed to accelerate the company’s next phase of growth. Jason Richardson has been appointed Chief Financial Officer, effective April 6, 2026.Richardson succeeds Michael Bourque, who will step down from his role as Chief Financial Officer on that date. Bourque will serve in an advisory capacity until June 30, 2026, to ensure a smooth transition. Dominic Hulton has been appointed Chief Marketing Officer, effective April 1, 2026. Mr. Hulton is a globally experienced commercial leader with over 20 years of experience driving growth, expanding markets, and leading organizational transformation in medical technology. Mr. Hulton spent the last 11 years at Insulet Corporation, where he served as Vice President of International Marketing and Sales Excellence. In that role, he led global product launches, built cross-functional teams and scaled commercial operations.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INGN:
- Inogen Earnings Call Shows Turnaround Amid Mixed Headwinds
- Inogen: Sustained Revenue Momentum, Margin Expansion, and New Product Pipeline Underpin Buy Rating
- Inogen reports Q4 EPS (26c) vs (41c) last year
- Inogen sees Q1 revenue in line with 1Q25
- Inogen sees FY26 revenue $366M-$373M, two estimates $385.2M
